Table 6.

Factors associated with a limited response to telitacicept identified by univariable and multivariable logistic regression analyses

	Univariable analysis		Multivariable analysis
	OR (95% CI)	P value	OR (95% CI)	P value
Age	1.06 (1.01 to 1.12)	0.021*	1.07 (1.00 to 1.14)	0.048*
Sex	3.00 (0.34 to 26.61)	0.290	3.14 (0.25 to 45.54)	0.366
Duration	1.07 (0.98 to 1.18)	0.132	1.01 (0.89 to 1.15)	0.825
GC dose	0.98 (0.94 to 1.01)	0.227	1.00 (0.94 to 1.05)	0.887
Number of immunosuppressants used	1.09 (0.50 to 2.44)	0.830	0.80 (0.29 to 2.24)	0.670
ANA titres	0.69 (0.12 to 5.32)	0.688	0.86 (0.11 to 9.37)	0.894
SLEDAI-2K	0.79 (0.64 to 0.93)	0.011*	0.75 (1.07 to 1.74)	0.020*
C3	3.68 (0.65 to 23.03)	0.145	1.04 (0.04 to 22.64)	0.981
C4	67.88 (0.10 to 53 896.68)	0.200	0.06 (0.00 to 2976.78)	0.606

*p<0.05

GC, glucocorticoid; SLEDAI-2K, SLE Disease Activity Index 2000.